Pharma Foods International Co., Ltd. (2929) Press Release
[Summary] Consolidated Financial Results for the Nine Months Ended April 30, 2026 (Under Japanese GAAP)
Earlier from Pharma Foods International
- Pharma Foods International: April 30, 2026 Research and Development PharmaGABA® New Scientific Study Published in Leading International Journal - Accelerating Global Expansion and Adoption in the Food & Beverage Category
- Pharma Foods International: April 6, 2026 Research and Development Pharma Foods Co., Ltd. Acquires Exclusive Rights to Advance First-in-Class Adrenomedullin Program for CADASIL Across Key Asian Markets
- Pharma Foods International: March 23, 2026 Investor Supplementary Materials of Consolidated Financial Results for the Six Months Ended January 31, 2026
- Pharma Foods International: February 16, 2026 Investor Notice Concerning Dividends of Surplus (Interim Dividend)